动态心脏监测市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

动态心脏监测市场按设备类型(ECG 监测器、事件记录器、植入式心脏循环记录器、移动心脏遥测等)和地理划分

市场快照

Ambulatory Cardiac Monitoring Market Share
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.2 %
Ambulatory Cardiac Monitoring Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

动态心脏监测市场的驱动因素是心脏病患病率的增加、极易患冠心病的老龄化人口的增长以及心脏监测设备的技术发展,这些设备可以最大限度地减少感染机会并提高设备的效率。 

根据世界卫生组织的报告,据估计,心血管疾病每年夺去 1790 万人的生命,占全球死亡人数的 31%。然而,感染率上升、与监测相关的高成本和严格的监管程序可能会限制动态心脏监测市场在预测期内的增长。

报告范围

动态心脏监测是一种观察和记录心脏电活动的方法。它是为日常活动完成的。大多数录音设备大约有手机那么大。每个动态心脏监测设备都具有使其更适合处理不同监测需求的功能。患者的需求将最终决定使用哪种设备来获得准确的诊断。

By Device Type
ECG Monitors
Event Recorders
Implantable Cardiac Loop Recorders
Mobile Cardiac Telemetry
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

心电监护仪预计具有显着的增长率

  • 随着心血管疾病(CVD)发病率的增加,长期心电图监测是必要的。通常,这个程序在医院是可能的。然而,随着无线心电图的引入,医生可以远程、及时地监测和诊断病人。市场上有两种不同类型的心电图监护仪,即心电监护仪和诊断心电图系统。
  • 无线心电监护仪是由许多市场参与者开发的。这些设备可用于持续监测患有 CVD 的患者,并在通常更容易治疗时发现问题,同时避免危及生命和昂贵的紧急入院。
  • 各个细分市场的频繁产品发布是推动市场发展的主要因素之一。例如,2018 年 9 月,提供流动医疗测试解决方案的医疗器械公司 Icentia Inc. 今天宣布,其 CardioSTAT 连续心电图监测系统已获得 II 类医疗器械 CE 标志的批准。
Ambulatory Cardiac Monitoring Market Trends

预计亚太地区在预测期内将以显着的复合年增长率增长

由于心血管疾病患病率的增加、技术的进步、经济的快速增长以及政府的积极举措,亚太地区预计将出现显着增长。此外,多项健康意识计划的推出、多种新产品的推出以及微创手术的新技术预计将加强亚太地区预测期内的增长前景。例如,2018 年,Qardio, Inc. 获得了澳大利亚治疗用品管理局 (TGA) 对其革命性心电图监测器 QardioCore 的批准。

Ambulatory Cardiac Monitoring Market Growth

竞争格局

由于存在大量市场参与者,动态心脏监测市场高度分散和集中。动态心脏监测市场的公司正在专注于各种增长战略,例如提高其市场占有率,如并购、合作伙伴关系、合作、地域扩张、新产品发布。 

例如,2018 年 5 月,GE 医疗与预防解决方案达成合作,为客户提供医院心脏站的扩展,并将 GE 医疗心电图服务扩展到家庭,为监测动态心电图患者创建更全面的解决方案。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Incidences of Cardiovascular Diseases

      2. 4.2.2 Advances in Ambulatory Cardiac Monitoring Devices

    3. 4.3 Market Restraints

      1. 4.3.1 Risk of Infection Due to Implantable Monitoring Devices

      2. 4.3.2 Price Sensitive Market

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Device Type

      1. 5.1.1 ECG Monitors

      2. 5.1.2 Event Recorders

      3. 5.1.3 Implantable Cardiac Loop Recorders

      4. 5.1.4 Mobile Cardiac Telemetry

      5. 5.1.5 Others

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States

        2. 5.2.1.2 Canada

        3. 5.2.1.3 Mexico

      2. 5.2.2 Europe

        1. 5.2.2.1 Germany

        2. 5.2.2.2 United Kingdom

        3. 5.2.2.3 France

        4. 5.2.2.4 Italy

        5. 5.2.2.5 Spain

        6. 5.2.2.6 Rest of Europe

      3. 5.2.3 Asia Pacific

        1. 5.2.3.1 China

        2. 5.2.3.2 Japan

        3. 5.2.3.3 India

        4. 5.2.3.4 Australia

        5. 5.2.3.5 South Korea

        6. 5.2.3.6 Rest of Asia-Pacific

      4. 5.2.4 Middle East and Africa

        1. 5.2.4.1 GCC

        2. 5.2.4.2 South Africa

        3. 5.2.4.3 Rest of Middle East and Africa

      5. 5.2.5 South America

        1. 5.2.5.1 Brazil

        2. 5.2.5.2 Argentina

        3. 5.2.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Medtronic plc

      2. 6.1.2 Abbott Laboratories

      3. 6.1.3 Boston Scientific Corporation

      4. 6.1.4 GE Healthcare

      5. 6.1.5 iRhythm Technologies Inc

      6. 6.1.6 Biotronik

      7. 6.1.7 Schiller

      8. 6.1.8 Medicomp Inc.

      9. 6.1.9 Biotelemetry

      10. 6.1.10 Applied Cardiac System

      11. 6.1.11 MicroPort

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Ambulatory Cardiac Monitoring Market market is studied from 2018 - 2026.

The Ambulatory Cardiac Monitoring Market is growing at a CAGR of 5.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

GE Healthcare, Medicomp Inc., iRhythm Technologies, Inc., BioTelemetry, Inc., Medtronic Plc are the major companies operating in Ambulatory Cardiac Monitoring Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!